US Stem Cell Inc (USRM)

[Poor Man -]

The Window is Closing.

Shareholders had a great opportunity to sell at higher prices while the gimmicks of the R/S and insider buys, and such, were in play.

But the window is now starting to close on that opportunity, and shareholders that didn't take advantage are in for a long ride down into sub $1 territory again.

The only hope is the company issues one of its meaningless press releases that provides just a little more crack below the window to escape from.